Meghmani Finechem informs about outcome of board meeting

21 Jul 2022 Evaluate
Meghmani Finechem has informed that it submitted Financial Results (Consolidated & Standalone) of the First Quarter ended on 30th June, 2022. The Statutory Auditors SRBC & CO LLP, Chartered Accountants have carried out a limited review Report on Un-audited Financial Results (Consolidated & Standalone) of the First Quarter ended 30th June, 2022 with unmodified opinion and the same is also forwarded.

The above information is a part of company’s filings submitted to BSE.

Epigral Share Price

1468.90 -7.60 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
BASF India 4039.90
Tata Chemicals 773.85
SRF 2886.20
Pidilite Inds. 1474.70
Deepak Nitrite 1565.30
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×